Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Chronic Myelomonocytic Leukemia in Remission
Known as:
CMML in Remission
, Chronic Myelomonocytic Leukaemia (in Remission)
Chronic myelomonocytic leukemia not growing; responding to treatment.
National Institutes of Health
Create Alert
Related topics
Related topics
2 relations
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.
P. Valent
Best practice & research. Clinical haematology
2020
Corpus ID: 213368417
Chronic myelomonocytic leukemia (CMML) is defined by myelodysplasia, pathologic accumulation of monocytes and a substantial risk…
Expand
2018
2018
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
H. Kim
,
K. O. Lee
,
+4 authors
H. Kim
Annals of laboratory medicine
2018
Corpus ID: 51702313
Background Molecular genetic abnormalities are observed in over 90% of chronic myelomonocytic leukemia (CMML) cases. Recently…
Expand
2018
2018
Alteration in the Cytokine Secretion of Bone Marrow Stromal Cells from Patients with Chronic Myelomonocytic Leukemia Contribute to Impaired Hematopoietic Supportive Activity
Hui Shi
,
Yingshao Wang
,
+4 authors
Y. Zhou
Stem cells international
2018
Corpus ID: 52038626
Bone marrow stromal cells (BMSCs) represent an important cellular component of the bone marrow microenvironment, which play an…
Expand
2018
2018
Blast-phase chronic myelomonocytic leukemia: more than just semantics
M. Patnaik
,
A. Tefferi
,
G. Garcia-Manero
Leukemia
2018
Corpus ID: 51934913
To the Editor, We thank the author for her comment and appreciate her concerns on the need for uniformity with regards to the…
Expand
Review
2016
Review
2016
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia.
P. Minetto
,
F. Guolo
,
M. Miglino
Leukemia research
2016
Corpus ID: 27427143
Itonaga et al. extensively evaluated the impact of Graft Versus ost Disease (GVHD) on the outcome of a large cohort of 141…
Expand
2013
2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia.
Koichi Takahashi
,
N. Pemmaraju
,
+8 authors
G. Garcia-Manero
Blood
2013
Corpus ID: 6697217
We sought to describe the clinical features and outcomes of therapy-related chronic myelomonocytic leukemia (t-CMML) and compare…
Expand
1998
1998
Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study.
C. Díaz de Heredia
,
J. Ortega
,
M. T. Coll
,
P. Bastida
,
T. Olivé
Medical and pediatric oncology
1998
Corpus ID: 22654517
BACKGROUND The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE